Patients with HAE Type 1 and 2 experience episodes of submucosal or subcutaneous (SC) edema (angioedema attacks) caused by the deficiency or dysfunction on C1INH leading to unregulated production of bradykinin and subsequent increased vascular permeability [14]. Here, KNG1 is linked to angioedema.